The iPad Air is my favourite all-rounder tablet, and it has $110 chopped off its price
I work on it, I game on it, I stream on it – and it’s buttery smooth to use.
I work on it, I game on it, I stream on it – and it’s buttery smooth to use.
Applications are now open for official National Team Partners to help build the foundation for a credible and sustainable nation-based esports competition EWCF to establish $20 million ENC Development Fund to support the long-term… Read More »Esports World Cup Foundation Introduces National Team Representation Framework for the Esports Nations Cup 2026
Elevating Employee Experience with 3CLogic’s AI-Powered Contact Center Integrated with ServiceNow HRSD ROCKVILLE, Md., Jan. 8, 2026 /PRNewswire/ — 3CLogic, the leading AI-powered contact center platform purpose-built for ServiceNow®, today announced that a major… Read More »Major Beauty Retailer Modernizes HR Service Delivery With 3CLogic Voice AI Integration
CHATTANOOGA, Tenn., Jan. 8, 2026 /PRNewswire/ — Cleanova, a leading global manufacturer of advanced industrial filtration solutions owned by PX3 Partners, the London-headquartered private equity firm, announces today the strategic acquisitions of two U.S.-based companies:… Read More »Cleanova Strengthens Filtration Portfolio with Strategic Acquisitions of Airflotek and TES-Clean Air Systems, Entering Ultra-Clean Controlled Environment Markets
Las Vegas, NV, Jan. 08, 2026 (GLOBE NEWSWIRE) — At CES 2026, Chinese innovator J-STYLE (Jointcorp / Youhong) drew global attention with its latest smart rings, AI smart bands, smart health watches, and biosensors integrated… Read More »CES 2026 Spotlight: J-STYLE Showcases Smart Wearables and AI Remote Health Management Solutions
The Cancerkit, a cancer treatment journal designed to help patients stay organized throughout treatment has been awarded the 2025 Best Cancer Treatment Journal for Patients in the US, a prestigious recognition that highlights its dedication… Read More »The Cancerkit Recognized as Best Cancer Treatment Journal for Patients in the US 2025